Background: Thoracic sympathectomy is used in the management of a variety of upper limb disorders. We have analyzed the evidence for thoracic sympathectomy in the management of digital ischemia.Methods: We reviewed the English literature between 1980 and 2010. Our analysis included reports with the clinical end points of relief, recurrence of symptoms or healing of ulcers, or both. Primary Raynaud disease (PR])) and secondary Raynaud phenomenon (SRP) were analyzed separately.Results: An initial postoperative positive effect was reported in 92% of PR]) patients and in 89% of SRP patients. Long-term beneficial effect was 58% for PRD and 89% for SRP. Ulcer healing or improvement was achieved in 95%.Conclusions: The available evidence suggests ...
ObjectiveVideothoracoscopic sympathecomy is a widely used treatment modality in patients with severe...
OBJECTIVE: To assess the minimally invasive single-port thoracoscopic sympathicotomy feasibility and...
Objective: Follow-up of patients with treatment-resistant Raynaud's phenomenon (RP) one-year after s...
Background: Thoracic sympathectomy is used in the management of a variety of upper limb disorders. W...
BackgroundThoracic sympathectomy is used in the management of a variety of upper limb disorders. We ...
INTRODUCTION: Thoracic sympathectomy is performed in the management of a variety of disorders of the...
We retrospectively reviewed the effectiveness of peripheral sympathectomy for severe Raynaud's pheno...
AbstractPurpose: For many years, thoracic sympathectomy via open surgery was not used to treat Rayna...
Digital ischemia is commonly found in patients with scleroderma and has been shown to respond to per...
Aim. To improve the results of surgical treatment of distal ischemia of the upper extremities by dev...
AbstractObjectivesTo assess the long term results of thoracoscopic sympathectomy for Raynaud's pheno...
Although the literature suggests that palmar sympathectomy (PS) with or without vascular reconstruct...
Raynaud’s phenomenon (RP) is the earliest and most common clinical manifestation of scleroderma, occ...
Introduction: Sympathectomy is used principally in patients of inoperable peripheral vascular diseas...
Background / Objective The Raynaud disease phenomenon is found in about 22% of the world's populatio...
ObjectiveVideothoracoscopic sympathecomy is a widely used treatment modality in patients with severe...
OBJECTIVE: To assess the minimally invasive single-port thoracoscopic sympathicotomy feasibility and...
Objective: Follow-up of patients with treatment-resistant Raynaud's phenomenon (RP) one-year after s...
Background: Thoracic sympathectomy is used in the management of a variety of upper limb disorders. W...
BackgroundThoracic sympathectomy is used in the management of a variety of upper limb disorders. We ...
INTRODUCTION: Thoracic sympathectomy is performed in the management of a variety of disorders of the...
We retrospectively reviewed the effectiveness of peripheral sympathectomy for severe Raynaud's pheno...
AbstractPurpose: For many years, thoracic sympathectomy via open surgery was not used to treat Rayna...
Digital ischemia is commonly found in patients with scleroderma and has been shown to respond to per...
Aim. To improve the results of surgical treatment of distal ischemia of the upper extremities by dev...
AbstractObjectivesTo assess the long term results of thoracoscopic sympathectomy for Raynaud's pheno...
Although the literature suggests that palmar sympathectomy (PS) with or without vascular reconstruct...
Raynaud’s phenomenon (RP) is the earliest and most common clinical manifestation of scleroderma, occ...
Introduction: Sympathectomy is used principally in patients of inoperable peripheral vascular diseas...
Background / Objective The Raynaud disease phenomenon is found in about 22% of the world's populatio...
ObjectiveVideothoracoscopic sympathecomy is a widely used treatment modality in patients with severe...
OBJECTIVE: To assess the minimally invasive single-port thoracoscopic sympathicotomy feasibility and...
Objective: Follow-up of patients with treatment-resistant Raynaud's phenomenon (RP) one-year after s...